XML 77 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-Term Obligations and Other Short-Term Borrowings
6 Months Ended
Dec. 31, 2019
Long-Term Obligations and Other Short-Term Borrowings [Abstract]  
Long-Term Obligations and Other Short-Term Borrowings
6. Long-Term Obligations and Other Short-Term Borrowings
Long-Term Debt and Other Short-Term Borrowings
At December 31, 2019 and June 30, 2019, we had total long-term obligations, including the current portion and other short-term borrowings, of $7.9 billion and 8.0 billion, respectively. All the notes represent unsecured obligations of Cardinal Health, Inc. and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. Interest is paid pursuant to the terms of the obligations. These obligations are effectively subordinated to the liabilities of our subsidiaries, including trade payables of 21.5 billion at both December 31, 2019 and June 30, 2019.
In November 2019, we repaid the full principal of the 2.4% Notes due 2019 at maturity for $450 million. During the six months ended December 31, 2019, we early repurchased $207 million of the 2.616% Notes due 2022, $10 million of the 3.2% Notes due 2022, $14 million of the Floating Rate Notes due 2022, $81 million of the 3.41% Notes due 2027, $6 million of the 4.6% Notes due 2043, $2 million of the 4.9% Notes due 2045, and $21 million of the 4.368% Notes due 2047. The repurchases were paid for with available cash and other short-term borrowings. In connection with the early debt repurchases, we recorded a $4 million loss on extinguishment of debt.

The following table summarizes long-term obligations and other short-term borrowings at:
(in millions) (1)
December 31, 2019
 
June 30, 2019
2.4% Notes due 2019
$

 
$
450

4.625% Notes due 2020
506

 
508

2.616% Notes due 2022
873

 
1,079

3.2% Notes due 2022
238

 
247

Floating Rate Notes due 2022
326

 
340

3.2% Notes due 2023
553

 
551

3.079% Notes due 2024
780

 
781

3.5% Notes due 2024
402

 
402

3.75% Notes due 2025
497

 
494

3.41% Notes due 2027
1,238

 
1,318

4.6% Notes due 2043
340

 
346

4.5% Notes due 2044
342

 
342

4.9% Notes due 2045
443

 
445

4.368% Notes due 2047
574

 
594

7.0% Debentures due 2026
124

 
124

Other Obligations (2)
698

 
10

Total
7,934

 
8,031

Less: current portion of long-term obligations and other short-term borrowings
1,192

 
452

   Long-term obligations, less current portion
$
6,742

 
$
7,579

(1)
Maturities are presented on a calendar year basis.
(2)
Includes $458 million outstanding under our commercial paper program and $225 million outstanding under our committed receivables sales facility.
Other Financing Arrangements
In addition to cash and equivalents and operating cash flow, other sources of liquidity include a $2.0 billion commercial paper program backed by a $2.0 billion revolving credit facility. We also have a $1.0 billion committed receivables sales facility. At December 31, 2019, we had $458 million outstanding under our commercial paper program, $225 million outstanding under committed receivables sales facility and no amount outstanding under our revolving credit facility.
In September 2019, we renewed our committed receivables sales facility program through Cardinal Health Funding, LLC (“CHF”) through September 30, 2022. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated with Cardinal Health, Inc. in accordance with GAAP, CHF is a separate legal entity from Cardinal Health, Inc. and from our subsidiary that sells receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors.
Our revolving credit and committed receivables sales facilities require us to maintain, as of the end of every fiscal quarter through December 2020, a consolidated net leverage ratio of no more than 4.00-to-1. The maximum permitted ratio will reduce to 3.75-to-1 in March 2021
and as of the end of every quarter thereafter. As of December 31, 2019, we were in compliance with this financial covenant.